Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin Action on Oxidative Stress and Inflammation in Type II Diabetes: The HDL Particle Protection Study

NCT02125682 is registered in ClinicalTrials.gov with Hotel Dieu de France Hospital as lead sponsor.

NCT NCT02125682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02125682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin Action on Oxidative Stress and Inflammation in Type II Diabetes: The HDL Particle Protection Study
Lead sponsor
Hotel Dieu de France Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2012
Completion date
May 14, 2017
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia in patients with diabetes mellitus